Literature DB >> 24154816

T cells in atherosclerosis.

Kevin Tse1, Harley Tse, John Sidney, Alex Sette, Klaus Ley.   

Abstract

Atherosclerosis is a chronic inflammatory disease of the artery wall. Atherosclerotic lesions contain monocytes, macrophages, smooth muscle cells and T lymphocytes. Here, we review the role of T-lymphocyte subsets in atherosclerosis. Among CD4⁺T cells, T(h)1 cells are pro-atherogenic, T(reg) cells are athero-protective and the role of T(h)2 and T(h)17 cells remains unclear. The role of follicular helper T cells in atherosclerosis remains unknown, as is the role of CD8⁺T cells. NKT cells bind glycolipid antigens and exert a pro-atherogenic role. The antigen specificity of T-cell responses in atherosclerosis is poorly understood. In order to enable antigen-specific prevention or therapy, a better understanding of these mechanisms is needed.

Entities:  

Keywords:  T cell; atherosclerosis; inflammation

Mesh:

Year:  2013        PMID: 24154816      PMCID: PMC3806170          DOI: 10.1093/intimm/dxt043

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  99 in total

1.  American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood.

Authors:  Rae-Ellen W Kavey; Stephen R Daniels; Ronald M Lauer; Dianne L Atkins; Laura L Hayman; Kathryn Taubert
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

Review 2.  The unconventional lifestyle of NKT cells.

Authors:  Mitchell Kronenberg; Laurent Gapin
Journal:  Nat Rev Immunol       Date:  2002-08       Impact factor: 53.106

3.  In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice.

Authors:  E Laurat; B Poirier; E Tupin; G Caligiuri; G K Hansson; J Bariéty; A Nicoletti
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

4.  Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice.

Authors:  Victoria L King; Stephen J Szilvassy; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

5.  Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse.

Authors:  Y Yang; M Bao; J W Yoon
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

Review 6.  Atherosclerosis as an autoimmune disease: an update.

Authors:  G Wick; H Perschinka; G Millonig
Journal:  Trends Immunol       Date:  2001-12       Impact factor: 16.687

7.  Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis.

Authors:  J Zhu; A A Quyyumi; D Rott; G Csako; H Wu; J Halcox; S E Epstein
Journal:  Circulation       Date:  2001-02-27       Impact factor: 29.690

8.  Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability.

Authors:  Z Mallat; A Corbaz; A Scoazec; P Graber; S Alouani; B Esposito; Y Humbert; Y Chvatchko; A Tedgui
Journal:  Circ Res       Date:  2001-09-28       Impact factor: 17.367

9.  Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.

Authors:  Gunilla Nordin Fredrikson; Ingrid Söderberg; Marie Lindholm; Paul Dimayuga; Kuang-Yuh Chyu; Prediman K Shah; Jan Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-20       Impact factor: 8.311

10.  Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.

Authors:  Gunilla Nordin Fredrikson; Bo Hedblad; Göran Berglund; Ragnar Alm; Mikko Ares; Bojan Cercek; Kuang-Yuh Chyu; Prediman K Shah; Jan Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-20       Impact factor: 8.311

View more
  64 in total

1.  Quantification of Various Inflammatory Cells in Advanced Atherosclerotic Plaques.

Authors:  Veronica Soundra Veena Paul; Christina Mary Priya Paul; Sarah Kuruvilla
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.

Authors:  Takayuki Kimura; Kevin Tse; Sara McArdle; Teresa Gerhardt; Jacqueline Miller; Zbigniew Mikulski; John Sidney; Alessandro Sette; Dennis Wolf; Klaus Ley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-13       Impact factor: 4.733

Review 3.  Interactions of hyperhomocysteinemia and T cell immunity in causation of hypertension.

Authors:  Sudhakar Veeranki; Siva K Gandhapudi; Suresh C Tyagi
Journal:  Can J Physiol Pharmacol       Date:  2016-04-28       Impact factor: 2.273

Review 4.  Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity.

Authors:  Maximilian J Schloss; Filip K Swirski; Matthias Nahrendorf
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 5.  The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective.

Authors:  Mia Krolikoski; James Monslow; Ellen Puré
Journal:  Matrix Biol       Date:  2018-05-21       Impact factor: 11.583

Review 6.  TREG-cell therapies for autoimmune rheumatic diseases.

Authors:  Makoto Miyara; Yoshinaga Ito; Shimon Sakaguchi
Journal:  Nat Rev Rheumatol       Date:  2014-07-01       Impact factor: 20.543

Review 7.  Mitochondrial ROS, uncoupled from ATP synthesis, determine endothelial activation for both physiological recruitment of patrolling cells and pathological recruitment of inflammatory cells.

Authors:  Xinyuan Li; Pu Fang; William Y Yang; Kylie Chan; Muriel Lavallee; Keman Xu; Tracy Gao; Hong Wang; Xiaofeng Yang
Journal:  Can J Physiol Pharmacol       Date:  2016-11-05       Impact factor: 2.273

Review 8.  Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.

Authors:  Charlotte Spitz; Holger Winkels; Christina Bürger; Christian Weber; Esther Lutgens; Göran K Hansson; Norbert Gerdes
Journal:  Cell Mol Life Sci       Date:  2015-10-30       Impact factor: 9.261

9.  miR-19a mitigates hypoxia/reoxygenation-induced injury by depressing CCL20 and inactivating MAPK pathway in human embryonic cardiomyocytes.

Authors:  Qiang Fu; Tao-Ran Mo; Xiao-Yang Hu; Yin Fu; Ji Li
Journal:  Biotechnol Lett       Date:  2020-11-09       Impact factor: 2.461

10.  Plasma phospholipid transfer protein (PLTP) modulates adaptive immune functions through alternation of T helper cell polarization.

Authors:  Catherine Desrumaux; Stéphanie Lemaire-Ewing; Nicolas Ogier; Akadiri Yessoufou; Arlette Hammann; Anabelle Sequeira-Le Grand; Valérie Deckert; Jean-Paul Pais de Barros; Naïg Le Guern; Julien Guy; Naim A Khan; Laurent Lagrost
Journal:  Cell Mol Immunol       Date:  2015-08-31       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.